MIFMISO
Live / Allowed — Third extension granted (statement of use) (as of 18 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 21 May 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98560902
- Mark type
- Word mark
- Filed
- 21 May 2024
- Published for opposition
- 21 Jan 2025
- Attorney of record
- F. Michael Sajovec
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical product for pregnancy and use in and treatment of pregnancy and pregnancy related conditions
Owner
- Conceptra Biosciences, LLC, Las Vegas, NV, US
- Conceptra Biosciences, LLC, Las Vegas, NV, US
Prosecution history
- 18 Aug 2026 — SOU EXTENSION 3 GRANTED
- 18 Aug 2026 — SOU EXTENSION 3 FILED
- 18 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 19 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Feb 2026 — SOU EXTENSION 2 GRANTED
- 18 Feb 2026 — SOU EXTENSION 2 FILED
- 18 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 20 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Aug 2025 — SOU EXTENSION 1 GRANTED
- 19 Aug 2025 — SOU EXTENSION 1 FILED
- 19 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jan 2025 — PUBLISHED FOR OPPOSITION
- 15 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED